Heterogeneity of DNA content in multiple synchronous hepatocellular carcinomas. 1997

A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
First Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

Heterogeneity of DNA content in multiple hepatocellular carcinomas (HCCs) was investigated by flow cytometry in 62 tumours from 26 patients who had undergone surgical treatment for multiple synchronous HCCs. Heterogeneity of DNA content was defined (a) when tumours had a different DNA ploidy pattern or (b) when the difference in the DNA index of the aneuploid clone was more than 0.1. A tumour with DNA aneuploidy was observed in 17 (66%) of the 26 patients. Heterogeneity of the DNA content was demonstrated in 12 (46%) out of 26 patients: in ten cases by definition (a) and in two cases by definition (b). Histological examination revealed that, of the 12 patients with a heterogeneous tumour DNA content, seven (58%) had a heterogeneous and the remaining five (42%) had a homogeneous type and grade of differentiation among the tumours, showing the absence of a relationship between histological heterogeneity and DNA content. The present results suggest the clinical relevance of DNA content analysis for identifying the clonal origin of multiple HCCs.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
November 1999, Gut,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
September 1992, Journal of hepatology,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
November 1990, Cancer,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
January 1987, Hepatology (Baltimore, Md.),
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
August 1990, Cancer,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
February 1993, Minerva chirurgica,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
October 1983, Minerva chirurgica,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
July 2001, Gut,
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
September 2009, Cancer prevention research (Philadelphia, Pa.),
A M Hui, and S Kawasaki, and H Imamura, and S Miyagawa, and K Ishii, and T Katsuyama, and M Makuuchi
October 2016, Nature communications,
Copied contents to your clipboard!